Diabetes Metabolic Syndrome and Obesity-Targets and Therapy-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2022-01-20 ms6000001368077955

投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊

68 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2023-02-26 ms3000000909608469 来自山西省

1a状态一周了还没有变，需要给编辑写信催一下吗

43 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2023-04-09 ms5000001014125810 来自新疆

审稿速度:1.0
偏重的研究方向：糖尿病
经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？

52 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2024-03-08 ms8000001966358118 来自安徽省

1A 10天了，这个状态正常吗，需要催一下编辑吗？

18 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2022-07-29 12381888m78暂无昵称

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问4C状态持续多久？

50 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2021-11-22 ms6000001781488545

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：糖尿病
经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗

75 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2021-04-20 叶豪

审稿速度:1.0
偏重的研究方向：糖尿病并发症;氧化应激
经验分享：请问有没有人一审修回后被拒的呢？

89 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2023-03-18 ms5000001014125810 来自新疆

偏重的研究方向：临床
经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。

45 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2021-03-02 1460b0a5m20(暂无昵称)

审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0
偏重的研究方向：肿瘤;遗传病;糖尿病
经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~

128 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1186533, encodeId=21ad118653303, content=投稿后好几天了状态一直是“1A - UNEVALUATED NEW SUBMISSION”，请问一般这个状态会持续多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4dca5491703, createdName=ms6000001368077955, createdTime=Thu Jan 20 18:29:17 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116604, encodeId=73b9211660456, content=1a状态一周了还没有变，需要给编辑写信催一下吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2e075730315, createdName=ms3000000909608469, createdTime=Sun Feb 26 21:14:01 CST 2023, time=2023-02-26, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2124586, encodeId=9d4e2124586c1, content=审稿速度:1.0 偏重的研究方向：糖尿病 经验分享：我现在是5ab状态，但什么邮件都没有，这是什么意思？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sun Apr 09 14:21:16 CST 2023, time=2023-04-09, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2192038, encodeId=6f30219203822, content=1A 10天了，这个状态正常吗，需要催一下编辑吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59789159425, createdName=ms8000001966358118, createdTime=Fri Mar 08 10:26:39 CST 2024, time=2024-03-08, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1235445, encodeId=c23d1235445d7, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问4C状态持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32b92414180, createdName=12381888m78暂无昵称, createdTime=Fri Jul 29 10:33:35 CST 2022, time=2022-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072751, encodeId=f26410e2751f3, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：2g状态了，有点紧张，想问一下这个状态被拒的多吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61285601573, createdName=ms6000001781488545, createdTime=Mon Nov 22 10:10:42 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958695, encodeId=a1ea958695b3, content=审稿速度:1.0 偏重的研究方向：糖尿病并发症;氧化应激 经验分享：请问有没有人一审修回后被拒的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97735429152, createdName=叶豪, createdTime=Tue Apr 20 11:34:25 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120304, encodeId=eb2b21203045e, content=偏重的研究方向：临床 经验分享：我在dovepress投稿，编辑就找了2个审稿人，现在修改意见回来了，编辑就让我完善一下，作者贡献部分，第一个审稿人意见文章逻辑性没问题，但需要改善语法，还有觉得研究结果不够创新，给了我一篇文章，相互对比，让我指出创新的点。第二个审稿人觉得创新性是足够的，给了我一篇文章，让我加到前言部分。我这个有没有被接受的可能性？修改意见给的不多。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a978456207, createdName=ms5000001014125810, createdTime=Sat Mar 18 16:21:37 CST 2023, time=2023-03-18, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=944837, encodeId=9d9794483e51, content=审稿速度:2.0 | 投稿命中率:75.0 | 版面费用:2500.0 偏重的研究方向：肿瘤;遗传病;糖尿病 经验分享：2020年7月22日投稿，9月份收到返修邮件，Author Dashboard提示小修后接收。于9月底提交返修稿，10月初针对一些小问题与编辑邮件沟通，官网提交修改文件。10月15日通知接收，并于11月18日见刊。第1篇被接收的SCI文章，很欣喜~审稿人非常友好，提出的修改意见也很专业。没有请翻译和润色，但审稿人和编辑在最终稿帮耐心地修改了文章中的文词native问题，小感动。无论审稿人、系统都很专业，遵照Dovepress系统流程即可投稿、返修、确认、发表，方便专业。版面费2500刀，可以接受~赞！希望日后还有合作~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a6f5107956, createdName=1460b0a5m20(暂无昵称), createdTime=Tue Mar 02 17:36:57 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921774, encodeId=d978921e74ed, content=有人最近投这个杂志了吗，交流一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54045173478, createdName=146e00b0m22(暂无昵称), createdTime=Sun Jan 31 22:22:15 CST 2021, time=2021-01-31, status=1, ipAttribution=)]

2021-01-31 146e00b0m22(暂无昵称)

有人最近投这个杂志了吗，交流一下

105 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务